Pfizer Share | Sustainability & Chart
US7170811035
Basic information on the Pfizer Share
Impact Score
Description Pfizer Share
Pfizer is a global pharmaceutical corporation developing and distributing a wide range of medications and health products, including vaccines and prescription drugs.
Pfizer Share Sustainability Performance
The company is sustainable in this area.
The company is not yet sustainable in this area.
The company is not sustainable in this area.
No data available.
Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable
Not yet sustainable
Not sustainable
No data
We measure the sustainability of companies based on 12 criteria. Learn more about our method.
Pfizer Share Performance
Chart powered by Eulerpool
Open an account now & invest sustainably
Ready to start investing? Open an account with a broker of your choice now.
Popular Brokers
Compare Pfizer with ...
Pfizer
?
Impact Score
Climate
Society
Gender
Sources of sustainability performance
| Metric | Value | Unit | Year | PDF Name | PDF Page | |
|---|---|---|---|---|---|---|
CEO-to-Employee Pay Ratio | ||||||
| 291 | Ratio | 2023 | 22cfe62a-6aef-4caf-9005-39d5888d3337.pdf | 94 | ||
| Dr. Albert Bourla | 2023 | 22cfe62a-6aef-4caf-9005-39d5888d3337.pdf | 5 | |||
Employee turnover rate | ||||||
| 12,5 | % | 2023 | Pfizer_2023_Impact_Report_11MAR2024.pdf | 51 | ||
Gender Pay Gap | ||||||
| 99,5 | % | 2023 | Pfizer_2023_Impact_Report_11MAR2024.pdf | 41 | ||
Glass Ceiling | ||||||
| 53,8 | % | 2023 | Pfizer_2023_Impact_Report_11MAR2024.pdf | 50 | ||
| 52 | % | 2023 | 1447e045-6320-4de3-a603-248c700cf342.pdf | 23 | ||
Greenhouse Gas Emissions | ||||||
| 88 000 | people | 2023 | 1447e045-6320-4de3-a603-248c700cf342.pdf | 23 | ||
| 500 077 | mt CO2e | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 1 | ||
| 620 124 | mt CO2e | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 1 | ||
Harassment and Discrimination at the Workplace | ||||||
| Yes | 2023 | Pfizer_2023BlueBook_English_v5_02272024.pdf | 7 | |||
| Yes | 2023 | Pfizer_2023BlueBook_English_v5_02272024.pdf | 2 | |||
| Yes | 2023 | Pfizer_2023BlueBook_English_v5_02272024.pdf | 8 | |||
| Yes | 2023 | Pfizer_2023BlueBook_English_v5_02272024.pdf | 8 | |||
Renewable Energy | ||||||
| 10 | % | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 1 | ||
Supply Chain | ||||||
| 500 077 | mt CO2e | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 1 | ||
| 620 124 | mt CO2e | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 1 | ||
| 88 000 | people | 2023 | 1447e045-6320-4de3-a603-248c700cf342.pdf | 23 | ||
| 4 338 487 | mt CO2e | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 1 | ||
Recycling and Recovery of Waste | ||||||
| 114,8 | thousand metric tons | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 2 | ||
| 28,9 | thousand metric tons | 2023 | 2023_KPI_Table_Final_June_2024.pdf | 2 | ||
Women on the Board | ||||||
| 12 | DIRECTOR | 2023 | 22cfe62a-6aef-4caf-9005-39d5888d3337.pdf | 16 | ||
| 4 | DIRECTOR | 2023 | 22cfe62a-6aef-4caf-9005-39d5888d3337.pdf | 16 | ||
| 12 | EXECUTIVE OFFICERS | 2023 | 1447e045-6320-4de3-a603-248c700cf342.pdf | 36 | ||
| 3 | OFFICERS | 2023 | 1447e045-6320-4de3-a603-248c700cf342.pdf | 36 | ||
Women in Management | ||||||
| 53,8 | % | 2023 | Pfizer_2023_Impact_Report_11MAR2024.pdf | 50 | ||
Find more sustainable shares
© 2025 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.Price data is provided by Eulerpool Research Systems.The source of ETF data is the websites and data sheets of the respective ETF providers.Logos provided by Clearbit (https://clearbit.com/). All trademarks and logos appearing on this website are the property of their respective owners and are used here for informational and educational purposes only, under fair use guidelines. We claim no affiliation with, nor endorsement by, the companies whose trademarks and logos are displayed. This website is independent of the brands analyzed and receives no direct or indirect compensation from them.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!